Wolverine Trading
BNTX icon

Wolverine Trading’s BioNTech BNTX Stock Holding History

Wolverine Trading’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.46M Buy
25,100
+3,400
+16% +$364K ﹤0.01% 1997
2025
Q2 		$2.32M Buy
21,700
+300
+1% +$30.3K ﹤0.01% 1598
2025
Q1 		$2.03M Buy
21,400
+200
+0.9% +$22.4K ﹤0.01% 1617
2024
Q4 		$2.39M Sell
21,200
-18,900
-47% -$2.16M ﹤0.01% 1808
2024
Q3 		$4.74M Buy
40,100
+12,900
+47% +$1.19M 0.01% 1073
2024
Q2 		$2.19M Buy
27,200
+3,300
+14% +$302K ﹤0.01% 1547
2024
Q1 		$2.2M Sell
23,900
-8,600
-26% -$825K ﹤0.01% 1537
2023
Q4 		$3.43M Buy
32,500
+15,800
+95% +$1.59M ﹤0.01% 1324
2023
Q3 		$1.81M Sell
16,700
-7,100
-30% -$785K ﹤0.01% 1663
2023
Q2 		$2.55M Buy
+23,800
New +$2.68M ﹤0.01% 1344
2023
Q1 		– Sell
-39,300
Closed -$5.9M – 4245
2022
Q4 		$5.9M Sell
39,300
-8,500
-18% -$1.31M 0.01% 810
2022
Q3 		$6.39M Sell
47,800
-6,200
-11% -$948K 0.01% 737
2022
Q2 		$7.67M Sell
54,000
-28,600
-35% -$4.37M 0.01% 627
2022
Q1 		$14.4M Sell
82,600
-86,500
-51% -$14.5M 0.02% 545
2021
Q4 		$43.4M Sell
169,100
-13,400
-7% -$3.67M 0.05% 256
2021
Q3 		$50.6M Buy
182,500
+69,500
+62% +$22.1M 0.06% 222
2021
Q2 		$25.8M Buy
113,000
+52,900
+88% +$9.98M 0.04% 336
2021
Q1 		$6.28M Buy
60,100
+21,600
+56% +$2.29M 0.01% 959
2020
Q4 		$3.23M Buy
+38,500
New +$3.78M 0.01% 1361

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wolverine Trading's BNTX Position: Q3 2025 in Review

Wolverine Trading increased its BioNTech (BNTX) stake by 43% in Q3 2025, buying an estimated $398K and bringing the position to 12,434 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Wolverine Trading first reported a position in BNTX in Q4 2020 and has held it in 16 quarters since. The position peaked at $5.09M in Q2 2021. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Wolverine Trading held 12,434 shares of BioNTech worth $1.22M as of Q3 2025.
  • Wolverine Trading bought 3,726 BioNTech shares in Q3 2025, an estimated $398K.
  • BioNTech made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2693 holding.
  • Wolverine Trading first reported a position in BioNTech in Q4 2020 and has held it in 16 quarters since.
  • Wolverine Trading's BioNTech position peaked at $5.09M in Q2 2021.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.